eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.60
-0.42 (-6.98%)
Jul 20, 2026, 4:00 PM EDT - Market closed
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $47.48 million as of July 20, 2026. Its market cap has decreased by -38.66% in one year.
Market Cap
47.48M
Enterprise Value
48.73M
1-Year Change
-38.66%
Ranking
Category
Stock Price
$5.60
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $47.48M, a decrease of -32.46%. That is a compound annual growth rate of -20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 47.48M | -48.06% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 53.11M |
| BeyondSpring | 53.04M |
| Seres Therapeutics | 51.62M |
| Immutep | 51.45M |
| Filana Therapeutics | 51.21M |
| INmune Bio | 50.51M |
| Instil Bio | 50.32M |
| aTyr Pharma | 49.99M |